Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Screening of Final API Powder – V 2.0

Posted on By

API Manufacturing: SOP for Screening of Final API Powder – V 2.0

Standard Operating Procedure for Screening of Final API Powder in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/078/2025
Supersedes SOP/API/078/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the standard procedure for screening of final Active Pharmaceutical Ingredient (API) powder before sampling, analysis, and packing, ensuring uniformity in particle size and elimination of foreign matter or lumps.

2. Scope

This SOP applies to all APIs manufactured in the facility that require screening prior to final sampling, testing, and packing. It covers manual and mechanical

screening using vibratory sifters or hand sieves.

3. Responsibilities

  • Production Operator: Perform screening as per defined mesh size and record activities.
  • Production Supervisor: Verify equipment setup, process parameters, and cleanliness before use.
  • QA Officer: Approve area and equipment line clearance before screening and verify final documentation.
See also  API Manufacturing: SOP for LOD Testing During Drying Stage - V 2.0

4. Accountability

The Production Head is accountable for proper execution of screening. QA Head is responsible for final approval and release of screened batch.

5. Procedure

5.1 Pre-Screening Preparation

  1. Ensure the drying operation is complete and final LOD results are within specification.
  2. Confirm the equipment (sieve, sifter, container) is cleaned and labeled “CLEANED”.
  3. Verify line clearance from QA using the Screening Line Clearance Checklist (Annexure-1).

5.2 Equipment Setup

  1. Choose appropriate sieve mesh size as per Master Batch Record (e.g., 40#, 60#, or 80#).
  2. Assemble the screen securely onto the sifter or frame.
  3. Ensure the container to collect screened API is clean and labeled with product details.
  4. Record equipment ID and sieve mesh size in the Batch Manufacturing Record (BMR).
See also  API Manufacturing: SOP for In-Process Sampling Technique - V 2.0

5.3 Screening Process

  1. Load dried API powder gradually into the screen feed hopper or tray.
  2. If using vibratory sifter, start the motor and set the vibration frequency (e.g., 30–50 Hz) based on product flow.
  3. Allow material to pass through completely, gently tapping or adjusting flow if clogging occurs.
  4. Visually check for any oversized material retained and document if any foreign matter is observed.
  5. Transfer the screened API into cleaned SS containers lined with double polybags.

5.4 Post-Screening Activity

  1. Weigh total quantity of screened API and update in the BMR.
  2. Label each container with:
    • Product Name
    • Batch No.
    • Net Weight
    • Screened on (Date)
  3. Submit sample for final analysis to QC.
  4. Clean equipment as per SOP/API/074/2025 and label “To Be Cleaned”.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • LOD: Loss on Drying
See also  API Manufacturing: SOP for Management of IPC Outliers and Investigations - V 2.0

7. Documents

  1. Screening Line Clearance Checklist (Annexure-1)
  2. Equipment Cleaning Record
  3. Batch Manufacturing Record

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA 21 CFR Part 211 – Current GMP for Finished Pharmaceuticals
  • Internal QA Guidelines for Equipment Usage

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Screening Line Clearance Checklist

Date Batch No. Sieve Size Area Clean Equipment Clean Line Cleared By (QA) Remarks
13/04/2025 API-20250413 60# Yes Yes Approved for screening

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New SOP QA Head
13/04/2025 2.0 Included vibratory sifter controls and checklist Regulatory Audit Feedback QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Maintaining Blinding in Blinded Studies – V 2.0
Next Post: Aerosol: SOP for Installation Qualification (IQ) of Aerosol Manufacturing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version